Tetrahydropalmatine promotes macrophage autophagy by inhibiting the AMPK/mTOR pathway to attenuate atherosclerosis.

Authors

Jiahong Wang (ORCID: https://orcid.org/0000-0003-3942-3257)
Ke Ding (ORCID: https://orcid.org/0000-0002-3877-0604)
Jiaqi He (ORCID: https://orcid.org/0000-0003-3985-5738)
Hui Wang (ORCID: https://orcid.org/0009-0006-3512-9308)

Institutions

Zhejiang Chinese Medical University (CN)

Publication Details

Journal: PubMed
Published: 2025-05-01
DOI: https://doi.org/10.14670/hh-18-809
Primary Topic: Autophagy in Disease and Therapy
Type: article
Field-Weighted Citation Impact: 0.00

Controls

|||

ALL TIME

JAN

FEB

MAR

APR

MAY

JUN

JUL

AUG

SEP

OCT

article

Tetrahydropalmatine promotes macrophage autophagy by inhibiting the AMPK/mTOR pathway to attenuate atherosclerosis.

Jiahong Wang, Ke Ding, Jiaqi He, Hui Wang

May 1, 2025

PubMed

Autophagy in Disease and Therapy

article

Tetrahydropalmatine promotes macrophage autophagy by inhibiting the AMPK/mTOR pathway to attenuate atherosclerosis.

Jiahong Wang, Ke Ding, Jiaqi He, Hui Wang

May 1, 2025article en

Abstract

No abstract available for this paper.

PubMedVol. 40(5)

Zhejiang Chinese Medical University (CN)

Openalex Percentile: Top 100%

Autophagy in Disease and Therapy

DOI Source OpenAlex

AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Tetrahydropalmatine promotes macrophage autophagy by inhibiting the AMPK/mTOR pathway to attenuate atherosclerosis. — Jiahong Wang, Ke Ding, et al. · PubMed (2025) | TGRS Research Map | TGRS